-
Mashup Score: 0Healthy Societies Need Healthy Women; Women’s Health Relies on Equitable Clinical Research - 1 year(s) ago
This Mother’s Day, women across the US and in other parts of the world will be celebrated, but this appreciation is not reflected in scientific research, where women continue to face stark inequities.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The global virtual clinical trials market is now worth $8 billion, according to Medi-Tech Insights, and is growing at a clip of more than 10% annually.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
Christine's experience participating in a DCT enabled her to receive the care she needs from home, without having to relocate or exhaust herself from lengthy travel burdens, which allowed her to return to her normal life. Read her story here: https://t.co/IsW7nQi9fi
-
-
Mashup Score: 1Representative Trials are Rocket Fuel for the Cancer Moonshot - 2 year(s) ago
In 2021, there were an estimated 1.9 million new cancer cases diagnosed in the US and 608,570 cancer deaths, or more than 166 deaths per day.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
"DCT technologies can save 35%, & potentially add 50% of a $150 million to $450 million gain in revenue by accelerating the trial processes", stated Sanskriti Thakur when discussing how DCT solutions could fast-track the Cancer Moonshot project. Read: https://t.co/RhRI86kRXK
-
-
Mashup Score: 1
Therapies based on RNA molecules have been researched for decades, initially showing promise in animal models and some ultimately in clinical trials. Research on messenger RNA-based (mRNA) vaccines started in the 1990s when the first mRNA flu vaccine was tested in mice.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
In @DrugInfoAssn's latest issue, Medable's Reem Yunis discusses how the extension of the Cancer Moonshot initiative, of which Medable is a proud member, will devote special attention to mRNA vaccines in #oncology research in the coming years. Read: https://t.co/OqQDuQJjPi
-
-
Mashup Score: 4
Given the complexity of cancer, some researchers are skeptical about the use of a decentralized clinical trial (DCT) model for oncology research. However, DCTs offer tremendous benefit, particularly in decreasing patient dropout rates and increasing patient engagement, two critical factors for oncology. Oncology represents the largest research area globally, with compared to 6.5% annual growth…
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
Read more from DIA Global here: https://t.co/w8mKPKnmOn
-
Does Modern Technology Deliver Better Data? DIA (@DrugInfoAssn) Global explores the Surprising Therapeutic Area Ripe for Decentralized Research: Oncology https://t.co/w8mKPKnmOn
-
-
Mashup Score: 1Is It Time to Screen for and Treat Early Multiple Myeloma? - 2 year(s) ago
Multiple myeloma (MM) is a blood cancer that evolves from the early precursor conditions of monoclonal gammopathy of undetermined significance (MGUS).
Source: DIA Global ForumCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @clonoSEQ: Read about early myeloma screening, by @IreneGhobrial and Dr. Lanny Kirsch. https://t.co/R480v2hzWn clonoSEQ is FDA-cleared t…
-
-
Mashup Score: 0
Given the complexity of cancer, some researchers are skeptical about the use of a decentralized clinical trial (DCT) model for oncology research. However, DCTs offer tremendous benefit, particularly in decreasing patient dropout rates and increasing patient engagement, two critical factors for oncology. Oncology represents the largest research area globally, with compared to 6.5% annual growth…
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
"We can now include remote real-time data capture for out-of-clinic insight on symptom development in direct correlation to treatment timing,” highlighted Medable's Dr. Oakley-Girvan. Read her insights on DCTs & the vital benefits they offer Oncology: https://t.co/aSCX0GIYQf
-
-
Mashup Score: 2Is It Time to Screen for and Treat Early Multiple Myeloma? - 2 year(s) ago
Multiple myeloma (MM) is a blood cancer that evolves from the early precursor conditions of monoclonal gammopathy of undetermined significance (MGUS).
Source: DIA Global ForumCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @LabGhobrial: Is it Time to Screen for MM precursors? #mmsm From @IreneGhobrial and @KirschLanny https://t.co/YMJ96Ft6bk
-
-
Mashup Score: 0Digital Biomarkers to Improve Quality of Life in Cancer Patients - 3 year(s) ago
The National Cancer Institute’s (NCI) Cancer Moonshot program was launched five years ago with the goal of generating new cancer research via an additional $1.8 billion investment into the 21st Century Cures Act.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet-
Learn more from Medable research leaders about the opportunities that our connected world & the NCI's Cancer Moonshot Program offer us to improve cancer patient care using digital biomarkers. Read here: https://t.co/UwFOZzd5ZI #decentralizedtrials #digitalbiomarkers https://t.co/ISy1HXxL6H
-
-
Mashup Score: 1
Innovations in molecular and genomic analysis have advanced our understanding of cancer biology and progression.
Source: DIA Global ForumCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @rschilsky: Advancing Precision Oncology: TADRUCA, A Model for Global Collaboration https://t.co/Uy4FOiSHLy
-
It's our duty to honor all women with actions toward equitable science & clinical research—which will directly improve global health for future generations. Learn more from Medable's CGO Sanskriti Thakur, here: https://t.co/binOyxCtxB #clinicaltrials #healthcare